Dr. Genovese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Jimmy Fund Way
SM-1158C
Boston, MA 02115Phone+1 617-582-9395
Summary
- Dr. Pietro Genovese is a pediatric hematologist/oncologist in Boston, MA and is affiliated with Boston Children's Hospital.
Education & Training
- Universita San RaffaeleClass of 2008
Publications & Presentations
PubMed
- 2 citationsBase Editing of Human Hematopoietic Stem Cells.Jing Zeng, Gabriele Casirati, My Anh Nguyen, Pietro Genovese, Daniel E Bauer
Methods in Molecular Biology. 2023-01-01 - 13 citationsTherapeutic gene editing of T cells to correct CTLA-4 insufficiency.Thomas Andrew Fox, Benjamin Christopher Houghton, Lina Petersone, Erin Waters, Natalie Mona Edner
Science Translational Medicine. 2022-10-26 - Editorial: Mutation-Specific Gene Editing for Blood Disorders.Carsten W. Lederer, Pietro Genovese, Annarita Miccio, Sjaak Philipsen
Frontiers in Genome Editing. 2021-09-29
Press Mentions
- New Gene Editing Strategy Could Lead to Treatments for People Born with Inherited Diseases of Immune SystemOctober 27th, 2022
- Genetic Cloaking of Healthy Cells Opens Door to Universal Blood Cancer TherapyJuly 16th, 2024
Grant Support
- Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid LeukemiaBOSTON CHILDREN'S HOSPITAL2024–2029
- Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid LeukemiaBOSTON CHILDREN'S HOSPITAL2024–2029
- Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid LeukemiaBOSTON CHILDREN'S HOSPITAL2024–2029
- Chemotherapy-free cure of hemoglobin disorders through base editingBOSTON CHILDREN'S HOSPITAL2023–2027
- Chemotherapy-free cure of hemoglobin disorders through base editingBOSTON CHILDREN'S HOSPITAL2023–2027
- Chemotherapy-free cure of hemoglobin disorders through base editingBOSTON CHILDREN'S HOSPITAL2023–2027
- Advanced Genetic Engineering to Unravel Tumor-Specific B Cell ResponsesBOSTON CHILDREN'S HOSPITAL2025–2026
- Development, Optimization and Preclinical Modeling of Hematopoietic Stem Cell Gene Editing for the Treatment of RAG1 ImmunodeficiencyBOSTON CHILDREN'S HOSPITAL2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: